Not directly related to RAC or oncology, however, I found this YouTube video provides an interesting insight and take on the US Big Pharma industry and the associated politics.
Katie Porter goes megaviral with MUST-SEE takedown during hearing - YouTube
My take-aways:
- plenty of cash to spend on non R&D activities, eg Dividends and stock buy-backs
- Big Pharma will need the potential of the R&D coming out of the likes of RAC to maintain their revenues to continue their spending
- When the time comes, Big Pharma should not have any problem writing big M&A cheques for innovative and game changing IP
Industry news, page-3
-
- There are more pages in this discussion • 2,105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.050(3.13%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.70 | $1.52 | $318.0K | 193.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 496 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 5484 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |